{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:15:40Z","timestamp":1767906940100,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.gore.2022.100961","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T21:51:09Z","timestamp":1647381069000},"page":"100961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recurrent granulosa cell tumor of the retroperitoneum during the COVID-19 Pandemic"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7628-1919","authenticated-orcid":false,"given":"Yasmin","family":"Abedin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upasana","family":"Madan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deena","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira C.","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2022.100961_b0005","series-title":"Ovarian Sex Cord-Stromal Tumors","first-page":"724","author":"Chi","year":"2017"},{"key":"10.1016\/j.gore.2022.100961_b0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/0970-9371.175527","article-title":"Primary granulosa cell tumor of retroperitoneal origin: A rare presentation with emphasis on cytomorphology","volume":"33","author":"Vasu","year":"2016","journal-title":"J. Cytol."},{"issue":"06","key":"10.1016\/j.gore.2022.100961_b0015","article-title":"Primary Retroperitoneal Granulosa Cell Tumor. UroToday","volume":"05","author":"Al-Shraideh","year":"2012","journal-title":"International J."},{"issue":"3","key":"10.1016\/j.gore.2022.100961_b0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3349\/ymj.2001.42.3.360","article-title":"Extraovarian granulosa cell tumor","volume":"42","author":"Kim","year":"2001","journal-title":"Yonsei. Med. J."},{"key":"10.1016\/j.gore.2022.100961_b0025","article-title":"Extraovarian granulosa cell tumor of mesentery: a case report","volume":"2010","author":"Naniwadekar","year":"2010","journal-title":"Patholog. Res. Int."},{"key":"10.1016\/j.gore.2022.100961_b0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/0377-4929.48928","article-title":"Extraovarian granulosa cell tumor","volume":"52","author":"Paul","year":"2009","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"1","key":"10.1016\/j.gore.2022.100961_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.1999.5375","article-title":"Extraovarian granulosa cell tumor","volume":"74","author":"Robinson","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"Suppl 4","key":"10.1016\/j.gore.2022.100961_b0040","first-page":"30","article-title":"Unusual case of extraovarian granulosa cell tumor","volume":"16","author":"Soydinc","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.gore.2022.100961_b0045","doi-asserted-by":"crossref","first-page":"100992","DOI":"10.1016\/j.inat.2020.100992","article-title":"Primary granulosa cell tumor of cerebellum: A rare case report","volume":"23","author":"Rauniyar","year":"2021","journal-title":"Interdisciplinary Neurosurgery"},{"key":"10.1016\/j.gore.2022.100961_b0050","unstructured":"National Comprehensive Cancer Network. Ovarian Cancer, including Fallopian Tube Cancer and Primary Peritoneal Cancer (Version 1.2021). 2021."},{"key":"10.1016\/j.gore.2022.100961_b0055","first-page":"393","article-title":"Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor","volume":"41","author":"Fishman","year":"1996","journal-title":"J. Reprod. Med."},{"issue":"2","key":"10.1016\/j.gore.2022.100961_b0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ygyno.2006.06.022","article-title":"Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases","volume":"103","author":"Freeman","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"13","key":"10.1016\/j.gore.2022.100961_b0065","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMoa1811714","article-title":"Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer","volume":"380","author":"Mehta","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7-8","key":"10.1016\/j.gore.2022.100961_b0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000341078","article-title":"Complete response in a patient with granulosa cell tumor treated with a combination of leuprolide and tamoxifen","volume":"35","author":"Keskin","year":"2012","journal-title":"Onkologie."},{"key":"10.1016\/j.gore.2022.100961_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2021.04.030","article-title":"Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer center","author":"Piedimonte","year":"2021","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578922000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578922000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:57:11Z","timestamp":1762480631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578922000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":15,"alternative-id":["S2352578922000418"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2022.100961","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent granulosa cell tumor of the retroperitoneum during the COVID-19 Pandemic","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2022.100961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100961"}}